The U.S. House of Representatives has voted overwhelmingly to pass the 21st Century Cures Act, a contentious, long-gestating piece of legislation with implications for drug approval standards at FDA. Members of the Senate are now set to discuss—and expected to pass—the legislation.

If the bill comes into force, NIH is in line to receive $4.8 billion in funding over the next 10 years. The cash is earmarked for the three landmark big science initiatives of President Obama’s time in office: The cancer moonshot, the BRAIN Initiative and the Precision Medicine Initiative.